 | | | | |
| |  | |  | | |
| |  |
| PRIME NEWS |  |
|
 |
|
|
Agilent Technologies has secured an exclusive license to Aktiv-Dry's CAN-BD drying technology for nucleic acid active pharmaceutical ingredients
|
|
|
|
|
|
|
|
|
Siemens Healthcare and Laboratory Corporation of America Holdings have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests
|
|
|
|
|
|
|
| | |
For all your information needs on medtech and biomedical technology devices read BioSpectrum Asia. The portal is updated every morning with the latest biomedical technology news & articles, trends and analysis, business and investment opportunities, medtech research & development breakthroughs, product features, event listings and job postings.
| | | | |  | |  | | |
|
|
|
|
|
|
 |
|
 |
|
|
|
 |
FEATURES |
 |
|
|
|
IT drives lifesciences
|
|
| IT has made inroads into the hitherto closed lifesciences sector and now is making its presence felt. |
|
|
|
|
|
Life Sciences Version 2.0
|
|
| Health Industry Insights (HII), an IDC company that provides market research and advisory services to health and life sciences industry, in January, released its series of top 10 predictions reports |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
Singapore to host 'BioMedical Asia 2008' on April 14
|
|
| Singapore, a hub for the biomedical industry in the Asian region will be hosting BioMedical Asia 2008 from April 14-17 where in more than 1,000 leading global biomedical industry players are expected to take part in conference and exhibition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
|
|
Stem cell science to support diabetes research
|
|
| According to Mr Arnold W Donald, stem cell science holds excellent promise as a tool for research for understanding normal and abnormal development, and for testing therapeutics for multiple diseases including diabetes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
|
|
Endeavor Zotarolimus-Eluting Coronary Stent approved
|
|
| The Endeavor is the first drug-eluting stent approved since 2004 and the first since FDA convened its Circulatory System Devices Panel in 2006 to discuss evidence of the rare risk of blood clots occurring in patients who receive drug-eluting stents. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
|
|
US dominates the global HTS market
|
|
| The global High Throughput Screening market was estimated at $ 11.3bn in 2007. The US dominates the market followed by Europe and the Asia Pacific region |
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
